New Study Finds Changes In Position Of Conventional Insulin Pumps Can Cause Fluctuations In Insulin Delivery Rates
Main Category: DiabetesAlso Included In: IT / Internet / E-mail; Conferences
Article Date: 15 Nov 2008 - 0:00 PDT
| Patient / Public: | ![]() |
3.33 (9 votes) |
| Healthcare Prof: | ![]() |
4 (1 votes) |
| Article Opinions: | 2 posts |
A new study presented at the Annual Meeting of the Diabetes Technology Society showed that changes in the position of a conventional insulin pump, relative to its infusion set, can significantly impact expected insulin delivery rates. Such changes may occur during routine daily activities such as getting dressed, sleeping or showering. This siphon effect has been reported previously in hospital IV pumps, but this is the first time it has been investigated in continuous subcutaneous insulin infusion pumps.
"Insulin pump therapy allows for precise control of insulin delivery for patients with type 1 diabetes. However, in this study, we saw that a conventional pump's insulin delivery rate can fluctuate significantly due to changes in the pump's height relative to its infusion set and the end of the tubing. This can increase blood glucose variability, which previous research has shown to be a risk factor for the progression of complications of diabetes," said lead investigator Howard Zisser, MD, Director of Clinical Research and Diabetes Technology at the Sansum Diabetes Research Institute in Santa Barbara, CA.
The investigators reached this finding by quantifying the effect of hydrostatic pressure (the pressure exerted on a portion of a column of fluid as a result of the weight of the fluid above it) on insulin delivery during bolus dosages, basal rates and static changes in insulin pumps. They tested conventional insulin pumps from Medtronic Diabetes (MiniMed 512 & 515, which uses 110 cm tubing) and Smiths Medical (Deltec Cozmo 1700, which uses 80 cm tubing), and also compared them to the tubing-free pump from Insulet Corporation (OmniPod).
They found that raising or lowering a conventional insulin pump, to the full extent of its tubing, can significantly affect the accuracy of insulin delivery, especially at low basal infusion rates. "This is particularly important for children, for whom low basal rates are often used," Dr. Zisser noted. The most pronounced differences were seen during basal delivery in the Cozmo and MiniMed pumps. For the 1U/hr rate, differences ranged from 74.5% of the expected delivery when the pumps were below the pipettes and pumping upward to 123.3% when the pumps were above the pipettes and pumping downward. For the 1.5U/hr rate, differences ranged from 86.7% to 117.0% when the pumps were below or above the pipettes, respectively.
In contrast, the OmniPod, which has no external tubing, was the least affected by pumping orientation and direction. For the 1U/hr rate, its differences only ranged from 98.3% when its delivery cannula was in a level pumping position to 101.3% when the cannula was in an upward pumping position. For the 1.5U/hr rate, its differences only ranged from 96.0% in a level pumping position to 102.5% in an upward pumping position.
The researchers measured the change in the fluid level in an in-line graduated glass pipette when the Cozmo and MiniMed pumps were moved either up or down to its maximum length in relation to the end of the tubing/pipette. For the OmniPod, the unit was held in a clamp vertically with the delivery cannula up for "upward" pumping position and the delivery cannula down for the "downward" pumping position. The OmniPod was horizontal for the level pumping position.
The study was supported by a grant from Insulet Corporation (Nasdaq: PODD) of Bedford, MA.
Sansum Diabetes Research Institute is a non-profit research center devoted to the prevention, treatment and cure of diabetes through research and education. In particular, it is known for its work on methods to detect and chart the progress of diabetes, its success in developing protocols to increase the incidence of healthy babies born to women with diabetes, and its expertise in new diabetes technology.
Sansum Diabetes Research Institute
http://www.sansum.org
Visit our diabetes section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/129510.php>
APA
http://www.medicalnewstoday.com/releases/129510.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
WHy Should We Beleive This?
posted by anon on 15 Nov 2008 at 12:47 pmWhy should people a study funded by Omnipod which says that their product work the best or has the smallest variation in delivery? Also, how many people do you think normally wear their insulin pump with the pump elevated or lowered to its maximum extent? I never have my tubing extended nearly as far as it can go (it is uncomfortable and may pull the infusion set out of my skin). If this study was done by a nonbiased group without funding from Omnipod, I may look at it and think twice about it, but not when Omnipod has paid for the "research".
Shawna
posted by Shawna on 15 Dec 2008 at 7:48 amIn response to "....how many people do you think normally wear their insulin pump with the pump elevated or lowered to its maximum extent?"
I, for one, wear my pump this way, and probably many others do as well, especially women. I use my thighs almost exclusively for infusion sites, with 23" tubing (I'm only 5'3"), and carry my MiniMed 515 in the fob pocket of my jeans. Depending on how far down my thigh my infusion site is, and which leg it's on, my tubing can be almost maximally stretched. Not enough to pull on the site, but enough that it is snug without a lot of extra tubing available, which I prefer. When I'm not carrying the pump in my pocket, I wear it in my bra, which a lot of women do, so it's even higher at that point. And then there are occasions when women wear dresses and wear the pump on their thighs, with sites in the abdomen or hip. And what about the people who infuse into their arms?
Not everyone uses their abdomen or hip for sites while also wearing their pump at their waste, so don't assume a wide number of people wouldn't be affected by this study if it is indeed true. I find the information a little disconcerting, but it may be an explanation for those times when you do everything the same as before and end up with vastly different results with no apparent explanation.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





